EMEA-001136-PIP02-19-M01

Table of contents

Key facts

Invented name
Doptelet
Active substance
Avatrombopag
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0482/2020
PIP number
EMEA-001136-PIP02-19-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Powder for oral suspension
Condition(s) / indication(s)
Treatment of chemotherapy-induced thrombocytopenia
Route(s) of administration
Oral use
Contact for public enquiries
Dova Pharmaceuticals Ireland Limited
E-mail: medical.info@sobi.com
Tel: +46 86972000
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating